Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).
暂无分享,去创建一个
Y. Loriot | K. Fizazi | A. Patrikidou | J. D. de Bono | G. Attard | C. Massard | S. Sandhu | L. Albiges | D. Bianchini | C. Pezaro | E. Ileana